Halozyme Therapeutics, Inc. (HALO)

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $6.53 billion as of July 2, 2024. Its market cap has increased by 45.23% in one year.

• Market Cap: 6.53B
• Enterprise Value: 7.57B
• 1-Year Change: 45.23%
• Ranking: #1063
• Category: Mid-Cap
• Stock Price: $51.30

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $6.53B, an increase of 80,506.87%. That is a compound annual growth rate of 39.03%.

Market Cap History

Date	Market Cap	% Change
Jul 1, 2024	6.62B	35.61%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%
Mar 16, 2004	8.10M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Repligen	6.89B
Ionis Pharmaceuticals	6.88B
Penumbra	6.86B
Blueprint Medicines	6.84B
Jazz Pharmaceuticals	6.71B
Exelixis	6.48B
Revolution Medicines	6.40B
Cytokinetics	6.27B